Combined use of CYFRA 21-1 and CA 125 predicts survival of patients with metastatic NSCLC and stable disease in IMpower150

User: Guest

Title:: Combined use of CYFRA 21-1 and CA 125 predicts survival of patients with metastatic NSCLC and stable disease in IMpower150
Document type:: Zeitschriftenaufsatz
Author(s):: Mang, Anika ; Zou, Wei ; Rolny, Vinzent ; Reck, Martin ; Cigoianu, Daniel ; Schulze, Katja ; Holdenrieder, Stefan ; Socinski, Mark A. ; Shames, David S. ; Wehnl, Birgit ; Patil, Namrata S.
Keywords:: Research Article ; Metastatic ; non-small cell lungcancer ; stable disease ; prognosis ; survival ; biomarkers
Journal title:: Tumor Biology
Year:: 2023
Journal volume:: 46
Journal issue:: s1
Pages contribution:: S177-S190
Fulltext / DOI:: doi:10.3233/tub-230001
Publisher:: SAGE Publications
E-ISSN:: 1010-4283 ; 1423-0380
Date of publication:: 02.08.2023
BibTeX

Occurrences: